Molecular Epidemiology and Resistance Patterns of Candidozyma auris in Guangzhou

Study Background and Research Question

Candidozyma auris (formerly Candida auris) is an emerging, multidrug-resistant fungal pathogen that has become a significant global health concern due to its rapid geographic spread, persistent nosocomial outbreaks, and challenging treatment landscape. The World Health Organization designates C. auris as a high-priority pathogen because of its ability to cause invasive, often hard-to-treat infections and its pronounced antifungal resistance. In China, although the first documented case appeared in 2018, recent epidemiological data reveal a dramatic rise in incidence, particularly in 2023, emphasizing an urgent need for regional molecular surveillance and resistance profiling. The present study by Wan et al. (BMC Microbiology, 2026) addresses this gap by investigating the molecular epidemiological characteristics, antifungal resistance mechanisms, and pathogenicity of C. auris isolates collected in Guangzhou, South China.

Key Innovation from the Reference Study

The principal innovation of this study lies in its integrated approach, combining whole-genome sequencing (WGS), antifungal susceptibility testing, enzymatic activity profiling, biofilm formation assessment, and in vivo pathogenicity modeling. By systematically characterizing 39 clinical isolates from 37 patients across three hospitals, the authors establish a detailed genomic and phenotypic map of C. auris circulating in this region. Notably, this work delineates clade-specific resistance and virulence traits, contributing new insights to the genetic database of C. auris and informing the development of targeted infection control and stewardship programs.

Methods and Experimental Design Insights

The study’s methodology hinges on several complementary pillars:

• Isolate Collection and Genotyping: 39 isolates from 37 patients were obtained from three Guangzhou hospitals. Whole-genome sequencing (WGS) enabled single nucleotide polymorphism (SNP) and phylogenetic analyses to classify clade distribution.
• Antifungal Susceptibility Testing: Standardized protocols were used to determine resistance profiles against fluconazole, echinocandins, and amphotericin B.
• Resistance Gene Analysis: Sequence analysis targeted known mutations in ERG11 (fluconazole resistance), FKS1 (echinocandin resistance), and other loci.
• Phenotypic Assays: Secreted aspartyl protease (SAP) activity, extracellular hydrolase production, and biofilm-forming capacity were quantified. Pathogenicity was evaluated using the Galleria mellonella infection model.

This multifaceted design enabled direct correlation between genetic markers, drug susceptibility, and in vitro/in vivo virulence phenotypes, providing a robust framework for regional epidemiological surveillance.

Core Findings and Why They Matter

Phylogenetic Structure: The isolates clustered into two major clades: Clade I (South Asia, 74.4%) and Clade III (South Africa, 25.6%). Strikingly, one patient was co-infected with isolates from both clades, highlighting the risk of mixed-clade transmission within healthcare environments (Wan et al., 2026).

Antifungal Resistance Profiles: All isolates exhibited high-level resistance to fluconazole, with Clade I isolates also displaying frequent resistance to amphotericin B. In contrast, all isolates remained susceptible to echinocandins. Genomic analysis revealed that all strains harbored ERG11 mutations (K143R or F126L) linked to azole resistance, but no mutations in FKS1 or amphotericin B-associated resistance genes were detected. These findings reinforce the need for precise antifungal stewardship, as local clade prevalence can shape optimal treatment strategies.

Virulence and Phenotype: Clade I isolates demonstrated robust secreted aspartyl protease (SAP) activity, which correlated with higher mortality in the Galleria mellonella infection model, indicating greater pathogenic potential. Conversely, Clade III isolates formed denser biofilms, a factor likely to facilitate skin colonization and persistence in healthcare settings. This clade-specific divergence in virulence traits underscores the importance of integrating molecular and phenotypic surveillance into infection control programs.

Implications: By establishing the genetic and phenotypic landscape of C. auris in South China, the study provides actionable data for regional infection control and supports the global effort to map clade distribution, resistance mechanisms, and virulence factors.

Comparison with Existing Internal Articles

The integration of biofilm quantification and virulence assessment in this study is closely aligned with recent technical discussions on the utility of nuclear staining dyes in fungal pathogenicity research. For instance, "Crystal Violet Staining Solution: Precision in Fungal Pathogenicity and Drug Resistance Assays" explores how robust nuclear staining enables accurate measurement of biofilm mass and cell viability, which are critical in evaluating antifungal resistance and virulence phenotypes. Additionally, "Crystal Violet Staining Solution: Precision Nuclear Stain in Cell Assays" discusses the mechanistic advantages of using crystal violet for quantifying cellular components in migration and colony formation assays, supporting workflows similar to those employed in the reference study.

While the reference study did not explicitly focus on optimizing staining protocols, its reliance on quantitative phenotype measurements highlights the value of validated nuclear staining dyes in experimental mycology. Cross-referencing these internal resources can inform best practices for workflow standardization and result interpretation.

Limitations and Transferability

Several limitations merit consideration. First, the study is geographically localized to Guangzhou, which may limit direct extrapolation of clade distribution and resistance rates to other regions. The sample size, though substantial for a regional cohort, may also not capture the full spectrum of genetic diversity or rare resistance mechanisms. Furthermore, pathogenicity was modeled in Galleria mellonella, an invertebrate system that, while informative, does not fully replicate mammalian immune responses. Finally, the clinical data underlying isolate acquisition were not deeply integrated into the analysis, precluding robust genotype-phenotype-outcome correlations.

Nevertheless, the combined genomic and phenotypic approach provides a transferable framework for similar surveillance studies in other settings, and the identified molecular markers and resistance mechanisms are broadly relevant to global C. auris research.

Protocol Parameters

• Isolate collection: Consecutive C. auris isolates from clinical specimens, with metadata on patient origin and hospital ward.
• Genotyping: Whole-genome sequencing coverage ≥30× for robust SNP calling and clade assignment.
• Antifungal susceptibility: Broth microdilution following CLSI or EUCAST standards; minimum inhibitory concentrations determined for fluconazole, amphotericin B, and echinocandins.
• Biofilm quantification: Crystal violet staining of 24–48 h in vitro biofilms, with absorbance measured at 570 nm post-solubilization.
• Protease activity: SAP detection via colorimetric substrates or agar-based halo assays, standardized against controls.
• Pathogenicity modeling: Infection of Galleria mellonella larvae with standardized inocula; survival assessed over 7 days.

Research Support Resources

For laboratories seeking to replicate or extend these workflows, the use of a validated nuclear staining dye is essential for robust quantification in cell-based assays. Crystal Violet Staining Solution (SKU K1184) is a 2% alkaline dye widely used for nuclear staining in colony formation, cell migration, and biofilm assays due to its strong affinity for nucleic acids and reproducible staining properties. According to the product information, it is supplied in convenient volumes and offers stability for up to one year when properly stored. While not suitable for diagnostic or medical use, it provides a reliable tool for scientific research in fungal pathogenicity and drug resistance studies.